In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hologic Grabs Gen-Probe

Executive Summary

Women’s health-focused Hologic is buying molecular diagnostics provider Gen-Probe for $3.7 billion in cash. Adding Gen-Probe’s automated instrument platforms gives Hologic critical mass in the molecular diagnostics market while allowing it to maintain its core focus on women’s health. Hologic’s international direct sales force and dealer network can further drive adoption of US-oriented Gen-Probe’s tests in both developed and emerging markets. It also gives Gen-Probe a much greater capability for selling to physicians as well as labs, filling a second significant gap in Gen-Probe’s marketing.


Related Content


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts